Patient Centricity is Changing the Pharmaceutical Industry
How the Patient Centricity is Changing the Pharmaceutical Industry Over the past few years, drug makers have partnered with patients to deliver better drugs, gain more feedback, and provide more information about their products. This renewed focus on patient...
What Pharma Can Learn from WannaCry
What Pharma Can Learn from WannaCry Over the past two weeks, healthcare networks across the globe have been infiltrated and patient data has been locked. These attacks, which are all connected to WannaCry ransomware, have spurred a conversation about what...
Trends Impacting Market Access and Coverage
The key to a successful product launch and quality patient care is market access and coverage. Obtaining high formulary coverage is crucial to ensuring patients' access to treatments and increases the likelihood of continued disease fighting development. The rapidly...
Navigating Software Updates in the Electronic Submission Process with Pfizer
In recent years, advancements in technology have enabled regulatory operations and affairs teams to develop electronic submissions, streamlining the application process.
How the FDA’s Medical Communications Guidances are changing Label Discussions
Innovations in a rapidly changing healthcare climate have presented challenges for medical information professionals tasked with communicating treatment abilities and uses.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Novo Nordisk Partners with Glooko to Unveil Diabetes Monitoring App
Novo Nordisk and Glooko have unveiled their co-created diabetes monitoring app, Cornerstones4Care, of C4C. The app combines Novo Nordisk’s existing online content with Glooko’s technology to sync blood glucose and activity data from any exercise or activity monitoring...
PhRMA Launches National Drug Price Campaign
PhRMA introduced its latest drug-cost campaign, “Let’s Talk About Cost,” this week. The campaign will serve as a digital, print, and social effort to discuss the rising costs of care, and how to combat them. PhRMA members met with President Trump earlier this year to...
Gilead Releases Granted Approval for Second-Line Hepatitis C Drug
Gilead was granted FDA approval this week for this latest Hepatitis C medication, Vosevi. The three-part pharmaceutical combines sofsbuvir and velpatasvir in a multi-week regime. The drug has been approved as a second-line defense. Vosevi has already been approved in...
GOP Leaders Kill Healthcare Bill, Move Ahead with Obamacare Repeal
The GOP has unveiled plans to move forward without replacing the ACA, and instead repealing the act without an approved healthcare bill. After inter-party opposition to the latest GOP bill, The Better Care Reconciliation Act of 2017, senate leaders have decided to...
CONTACT US
Q1 Productions
1 W Monroe St 4th Floor
Chicago, IL 60603
T: +1 (312) 822-8100
hello@q1productions.com